Human Liver Models Market Revenue Analysis & Region and Country Forecast To 2028

Comments · 547 Views

global human liver models market size is expected to reach USD 5.5 Billion by 2028 and register a CAGR of 13.9% over the forecast period

 

 

Rising need for early drug toxicity detection, increasing funding for research and initial capital investments to develop organoids, and rising prevalence of liver disorders are some key factors augmenting market growth

The global human liver models market size is expected to reach USD 5.5 Billion by 2028 and register a CAGR of 13.9% over the forecast period, according to the latest report by Reports and Data. Increasing emphasis on developing enhanced liver models as an alternative to animal testing models is boosting global human live models market revenue growth currently. 

The liver plays a vital role in a variety of functions such as production of bile, blood clotting synthesis, and synthesis of glucose. Liver models are obtained from single fetal progenitor live cells. These models offer a virtual ecosystem that mimics molecular process, physiology, and anatomy of the liver. These liver models are known as organoids and are gaining increasing preference over animal testing models. High adoption of human liver models for novel drug screening, increasing investments in research and development activities by leading companies, and government initiatives to promote liver organoids are factors fueling market growth. Rising prevalence liver infections and utilization of liver models for developing various drugs and gene therapy is further augmenting growth of the global market.

Emulate Inc., Ascendance Bio, Organovo Holdings Inc., CN Bio Innovations, Cyfuse Biomedical, HìREL, InSphero, BioIVT, and Mimetas. The report is formulated with thorough primary and secondary research and is verified by experts and professionals in the industry. The data is well-represented through charts, graphs, tables, figures and other pictorial presentations.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4015

Market Overview:

The global Human Liver Models market has significantly grown over the recent past and is expected to register rapid growth over the forecast period of 2021 to 2028. The pharma and healthcare sector is rapidly evolving with innovations in technology, increasing healthcare spending and improving healthcare facilities and systems. Many hospitals, ambulatory surgical care centers and clinics across the globe are adopting advanced devices and equipment. Revenue growth of the global Human Liver Models market is significantly driven by factors such as increasing prevalence of chronic diseases, rapid advancements in healthcare and medical sector, high adoption of latest tools and techniques and growing funds by several public and private sectors. In addition, rising focus on drug development, increasing demand for precision medicine, high adoption of home care settings and point-of-care diagnostics, increasing investments in research and development activities are expected to drive global market revenue growth during the forecast period.  

The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.

Request a Order on the report @ https://www.reportsanddata.com/report-pricing/4015

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as RD investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.  

Human Liver Models Market Segmentation:

Based On Type: (Revenue, USD Billion, 2018 - 2028)

  • Liver Organoids
  • Liver-on-a-chip
  • 2D Models
  • Animals Models
  • 3D Bioprinting

Based On Application: (Revenue, USD Billion, 2018 - 2028)

  • Educational
  • Drug Discovery
  • Others

Based On End Use: (Revenue, USD Billion, 2018 - 2028)

  • Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Others

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East Africa)

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4015

Thank you for reading the research report on global Human Liver Models market. Kindly contact us to know more about the customization feature and our team will offer the best suited report as per your requirement.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

 

 

 

 

 

Comments